Back to search

Article

Update on the use of Sodium Glucose Cotransporter Type 2 inhibitors in kidney transplant patients

2024-05-27

Abstract excerpt

Abstract Sodium glucose cotransporter type 2 inhibitors are a new class of drugs acting on cardiovascular system, renal and metabolism in a multiple way. Indeed, even their principal action is on the transporter of sodium and glucose in the convoluted distal tubule, they have multiple actions as antifibrotic and endothelial protective action. Their principal mechanism consist in the loss of sodium and glucose. The...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
25eb458e-6ee3-544e-8340-84a267c753ac
DOI
10.20944/preprints202405.1755.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Update on the use of Sodium Glucose Cotransporter Type 2 inhibitors in kidney transplant patientsDOI 10.20944/preprints202405.1755.v1
Extraglycemic effects of sodium glucose cotransporter 2 inhibitors with a systemic approach, from possibilities to certaintySemantic proximity
Review on pathophysiology and treatment of diabetic kidney disease.Semantic proximity
Renal outcomes of combination therapy with sodium-glucose cotransporter 2 inhibitors plus renin-angiotensin system blockers in patients with type 2 diabetes mellitus: A population-based cohort studySemantic proximity
Treatment of cardiovascular and renal risk factors in the diabetic hypertensive.Semantic proximity
The Efficacy and Safety of SGLT2 Inhibitors in Diabetes Kidney Transplant Recipients: A Systematic Review and Meta-AnalysisSemantic proximity
A Bioinformatics Investigation into the Pharmacological Mechanisms of Sodium-Glucose Co-transporter 2 Inhibitors on Diabetes Mellitus and Heart Failure based on Network PharmacologySemantic proximity
[Emerging new aspects on diabetic nephropathy].Semantic proximity
Chronic Kidney Disease in the Elderly Patient with DiabetesSemantic proximity
The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot studySemantic proximity
Treatment Response to SGLT2 Inhibitors: From Clinical Characteristics to Genetic VariationsSemantic proximity
Inhibiting renal sodium-glucose transport in diabetes: pass the salt.Semantic proximity
Mendelian randomization study of sodium-glucose cotransporter 2 inhibitors in cardiac and renal diseases.Semantic proximity
Select a neighboring publication to make it the new centre.